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Various factors play an essential role in patterning the digestive tract. During development, Sox2 and Cdx2 are exclusively expressed
in the anterior and the posterior parts of the primitive gut, respectively. However, it is unclear whether these transcription factors
influence each other in determining specification of the naı¨ve gut endoderm. We therefore investigated whether Sox2 redirects the
fate of the prospective intestinal part of the primitive gut. Ectopic expression of Sox2 in the posterior region of the primitive gut
caused anteriorization of the gut toward a gastric-like phenotype. Sox2 activated the foregut transcriptional program, in spite of
sustained co-expression of endogenous Cdx2. However, binding of Cdx2 to its genomic targets and thus its transcriptional activity
was strongly reduced. Recent findings indicate that endodermal Cdx2 is required to initiate the intestinal program and to suppress
anterior cell fate. Our findings suggest that reduced Cdx2 expression by itself is not sufficient to cause anteriorization, but that Sox2
expression is also required. Moreover, it indicates that the balance between Sox2 and Cdx2 function is essential for proper speci-
fication of the primitive gut and that Sox2 may overrule the initial patterning of the primitive gut, emphasizing the plasticity of the
primitive gut.
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Introduction
The vertebrate digestive tract develops through a complex
mechanism of patterning, expansion and differentiation of the
primitive gut, which itself is formed after gastrulation as a
result of folding of the definitive endodermal layer (Wells and
Melton, 1999, 2000; Zorn and Wells, 2009). One of the earliest
steps in patterning of the primitive gut is the regionalization
into the anterior and the posterior domain, which correlates
with the expression of two transcription factors, Sox2 and Cdx2,
respectively (Sherwood et al., 2009). During development these
domains become more subdivided and by E9.5, the foregut,
midgut, and hindgut regions can be discriminated. The foregut
eventually gives rise to the esophagus, stomach, and proxi-
mal part of the duodenum; the midgut develops into the caudal
part of the duodenum, jejunum, ileum, caecum, and proximal
part of the colon; and the hindgut forms the caudal part of the
colon and rectum. Once regionalization has occurred, the gastro-
intestinal tract becomes specified and cells differentiate into the
characteristic types found in the various regions.
Sox2 is a member of a highly conserved family of transcription
factors founded by the sex-determining gene Sry. Although indi-
vidual Sox proteins share common DNA-binding properties,
their specificity is the result of their expression pattern and
their ability to associate with different partners (Kondoh and
Kamachi, 2010; Kormish et al., 2010). Sox proteins are recognized
as key players in the regulation of embryonic development and
determination of cell fate and we recently described two novel
partners for Sox2 (Gontan et al., 2009; Engelen et al., 2011).
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Sox2 plays an important role during early vertebrate embryogen-
esis and is required later in development in the brain, neural tube,
germ cells, and in the foregut and its derivatives (Ishii et al., 1998;
Avilion et al., 2003; Taranova et al., 2006; Gontan et al., 2008;
Favaro et al., 2009; Que et al., 2009).
Expression of Sox2 starts at the 4–8 cell stage of embryonic de-
velopment and Sox2 gene inactivation results in early peri-
implantation lethality (Avilion et al., 2003). Modulating expres-
sion in mice showed the importance of Sox2 in the differentiation
of the esophageal epithelium and morphogenesis of the esopha-
gus and trachea (Que et al., 2007, 2009; Gontan et al., 2008).
Several congenital malformations in humans, for instance anoph-
thalmia, microphthalmia, and the anophthalmia–esophageal–
genital syndrome (Williamson et al., 2006), have been found to
be associated with heterozygote mutations in SOX2. In addition,
Sox2 is one of the key players in the induction of pluripotent stem
cells from somatic cells (Jaenisch and Young, 2008), confirming
the importance of Sox2 in development and differentiation
processes.
Cdx2 is a homeobox transcription factor involved in the estab-
lishment of the anterior–posterior polarity of the gut endoderm
and is expressed from E8.5 in the posterior part of the gut
(Beck et al., 1995). Later in development, Cdx2 becomes
restricted to the intestinal epithelium, with a sharp boundary,
marking the transition from stomach to duodenum (James and
Kazenwadel, 1991; James et al., 1994; Chawengsaksophak
et al., 1997; Sherwood et al., 2009).
Conditional ablation of Cdx2 from the developing gut endoderm
results in severe malformation of the intestinal tract and anterior-
ization of the posterior gut, evidenced by changes in the expres-
sion pattern of various transcriptional regulators (Gao et al.,
2009). Interestingly, quantitative RNA expression analysis of
Cdx2 mutant intestinal samples demonstrated ectopic activation
of Sox2 expression in the posterior region. The aberrant expres-
sion of Sox2 after Cdx2 ablation coincided with an early anterior-
ization event of the gut. The apparent reciprocal expression
pattern of Sox2 and Cdx2 suggests that these factors are able
to influence each other. However, it remains unclear whether
Sox2 or Cdx2 has a dominant role in determining the fate of the
developing gut endoderm. In addition, aberrant SOX2 expression
may underlie the formation of gastric metaplasia associated with
intestinal inflammation (Shaoul et al., 2000), and the formation of
various human congenital anomalies of the gut, such as Meckel’s
diverticulum in which ectopic gastric tissue can be present in the
small intestine (Lambert et al., 2000). Furthermore, our group and
others have observed aberrant expression of SOX2 in human
colorectal cancers, suggesting a role for SOX2 in colorectal
tumor initiation or progression (unpublished data; Park et al.,
2008).
Therefore, we ectopically expressed Sox2 in epithelial cells of
the prospective intestinal part of the primitive gut to investigate
whether Sox2 is able to change the differentiation of the develop-
ing gastro-intestinal tract. Our data show that expression of Sox2
in the embryonic mouse intestinal epithelium leads to a fluid-
filled, translucent swollen intestine with aberrant villi. The prolif-
eration of epithelial cells in the Sox2 expressing intestines are no
longer confined to the crypts, but rather distributed randomly
throughout the intestinal epithelium. Moreover, Sox2 induced
the expression of esophageal and stomach specific markers,
resulting in an anteriorization of the intestinal epithelium.
Although the expression level of Cdx2 is unaffected by ectopic
Sox2 expression, we further show that induction of Cdx2 target
gene expression is strongly reduced, because Sox2 leads to a
reduced binding of Cdx2 to its target genes.
These findings provide strong evidence that expression of Sox2
in the developing gut drives the activation of the foregut tran-
scriptional program and leads to conversion from an intestinal
into a premature gastric epithelium, despite simultaneous expres-
sion of Cdx2. This indicates that the balance between Sox2 and
Cdx2 function is essential for proper specification of the primitive
gut and that Sox2 can exert a dominant effect over Cdx2 to alter
intestinal cell fate by redirecting the intestinal transcriptional
program, emphasizing the plasticity of the primitive gut.
Results
Ectopic Sox2 expression in the caudal part of the developing gut
endoderm
Sox2 expression in the developing gut is restricted to the ante-
rior part, which forms the stomach and other foregut derivatives.
The posterior part is devoid of Sox2 expression, but expresses the
homeobox protein Cdx2. Expression of Sox2 and Cdx2 is
thought to be mutually exclusive, but it is unclear whether one
has a dominant effect on the determination of the fate of the
developing gut endoderm. Therefore, we investigated the role
of Sox2 in the patterning of the primitive gut and its influence
on Cdx2 expression.
Conditional expression of Sox2 in the intestinal epithelium was
achieved by crossing mice carrying a myc-tagged Sox2 gene
under the control of a tet-inducible promoter with the Villin-rtTA
transgenic mouse line, which drives expression of the reverse
tetracycline transactivator (rtTA) gene in all intestinal epithelial
cells (Gontan et al., 2008; Roth et al., 2009). The rtTA protein
drives expression of the Sox2 transgene in the intestinal epithe-
lium in a doxycycline-dependent manner. Induction of Sox2 in
embryos was achieved by administration of doxycycline to the
mother from E8.5 onward. Double transgenic pups that received
doxycycline through their mother were born at Mendelian ratio,
but failed to thrive. Therefore, pups were isolated at E18.5 by cae-
sarean section in order to investigate the intestinal abnormalities.
Externally, the littermates showed no significant morphological
abnormalities and all the embryos were equally well developed.
Intestinal tracts isolated from the pups carrying only one of the
two transgenes, or non-induced myc-Sox2/Villin-rtTA double
transgenic animals, appeared indistinguishable from non-
transgenic control animals and showed no macroscopic or micro-
scopic abnormalities. However, isolation of the gastro-intestinal
tract of double transgenic embryos that received doxycycline im-
mediately revealed major differences compared with single or
non-transgenic animals (Figure 1A). In all the double transgenic
pups, ectopic expression of Sox2 in the intestinal tract resulted
in markedly abnormal intestines that were translucent and fluid-
filled. Immunohistochemical analyses using an antibody against
Sox2 (Figure 1B), or an antibody against the N-terminal
myc-epitope present in the transgenic Sox2 protein (data not
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shown), revealed that nuclear Sox2 was expressed throughout
the entire intestinal epithelium of the double transgenic
animals. Assessment of Sox2 expression at specific time points
of development, i.e. E.10.5, E12.5, E14.5, and E16.5, revealed
that robust Sox2 expression could be detected only in the
double transgenic intestinal epithelium from E14.5 onward
(Supplementary Figure S1A), coinciding with the phase of cell
specification in the embryonic gut. The level of ectopic Sox2 ex-
pression was compared with endogenous Sox2 levels in the
stomach by quantitative polymerase chain reaction (qPCR) ana-
lysis, and a 6-fold increase in RNA level was found
(Supplementary Figure S1B). As Sox2 expression in the E18.5 em-
bryonic stomach is restricted to the basal cells of the foresto-
mach, the qPCR analysis will likely overestimate transgenic
Sox2 expression. Therefore, we compared expression levels by
immunohistochemistry (IHC) at limiting antibody concentrations,
showing that on a cell-to-cell basis transgenic Sox2 is expressed
only at slightly higher levels than endogenous stomach Sox2
(Supplementary Figure S1C).
Ectopic Sox2 expression causes alterations in proliferation and
malformation of the developing intestinal tract
Cross-sections of the intestines ectopically expressing the Sox2
transgene showed a 2-fold increase in luminal space
(Supplementary Figure S2). In addition, the small intestines did
not form true, morphological villi. Even the epithelial folds that
resembled villi were markedly reduced per equivalent surface
area (Figure 1B).
One possible explanation for the dilated intestinal tract could
be a disturbed balance between proliferation and apoptosis.
Using Ki67 staining to mark cycling cells (Figure 1C and
Supplementary Figure S3A), we observed that proliferation in
the cells of the double transgenic animals was no longer confined
to the intervillous, primitive crypt regions as in the controls, but dis-
tributed randomly throughout the epithelium of Sox2 expressing
embryos. In addition, the total number of Ki67-positive epithelial
cells increased from 35%–40% in controls to 85%–90% in the
Sox2-expressing embryos (Supplementary Figure S3A). Staining
for activated caspase 3 revealed no differences in apoptosis (data
not shown).
Thus, ectopic expression of Sox2 impairs villus formation and
greatly alters the appearance of normal intestinal epithelium.
These changes are accompanied by an increase in the number
and mislocalization of cycling cells.
Ectopic Sox2 expression in the intestine results in loss of
intestinal identity
Next, we analyzed the differentiation potential of the embryonic
intestinal epithelium to understand the phenotypic abnormalities
observed in the Sox2 expressing intestines. Both mucin2 (Muc2)
IHC and qPCR showed a dramatic loss in the number of intestinal
mucin-producing goblet cells in the double transgenic animals
(Figure 2A and C and Supplementary Figure S3B). Similar results
were obtained for enterocytes using qPCR for Lactase (Lct)
(Figure 2C). We also observed reduced numbers of synaptophysin
(Syp) positive cells and reduced expression of Chromogranin A
(ChgA), both markers for enteroendocrine cells though not exclu-
sive for the intestinal epithelium (Figure 2B and C and
Supplementary Figure S3C). In addition, periodic acid schiff (PAS)
staining demonstrated that the intestinal brush border layer was
entirely absent in the double transgenic animals, while clearly
present in the controls (Figure 2D). As the brush border contains
several transporters for micronutrients, lack of absorption across
this border may explain both the dilatation of the small intestine
and the fluid retention we observed. We tested the expression
level of several transporters expressed in the intestinal epithelium
by qPCR. Analysis of two members of the solute carrier family,
Slc2a2 and Slc5a1, which are responsible for active and passive
glucose transport, respectively (Wright et al., 2003), showed that
these genes were downregulated in the double transgenic
animals (Figure 2C). In addition, the expression levels of several
members of the Aquaporin family, which are of major importance
Figure 1 Ectopic expression of Sox2 severely affects the intestinal tract. (A) Macroscopic appearances of the digestive tracts from stomach until
rectum isolated at E18.5 of a non-transgenic embryo (top) and double transgenic embryo treated with doxycycline (bottom), showing that Sox2
induction leads to dilated and fluid-filled intestines. Scale bar, 2 mm. (B) IHC using an antibody against Sox2 on cross-sections of the duode-
num, jejunum, ileum, and colon reveals specific nuclear staining in the epithelium of double transgenic animals throughout the intestinal tract,
whereas Sox2 is absent in the control. Scale bar, 50 mm. (C) IHC using an antibody against Ki67 shows an increased number of cycling cells in
the double transgenic embryos, compared with control intestine. Moreover, proliferating cells were randomly distributed throughout the intes-
tinal epithelium of the double transgenic animals, whereas proliferation is restricted to the prospective crypt compartment at the base of villi in
control intestines. Scale bar, 20 mm.
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for water transport, were downregulated, as shown by qPCR
(Supplementary Figure S4).
Overall, ectopic expression of Sox2 in the embryonic intestinal
epithelium results in loss of intestinal identity which is accompan-
ied by reduced expression of various transporters.
Sox2 expression in the intestine results in cell fate conversion
In order to better understand the underlying changes induced by
expression of Sox2 in the intestinal epithelium, we performed
microarray analysis using intestines of E18.5 pups of three
control and two double transgenic animals, which received doxy-
cycline from E8.5 onward. Hierarchical clustering of differentially
expressed genes revealed large differences between controls and
double transgenic intestines (Figure 3A). Differentially expressed
genes in the Sox2-induced animals are involved in development
and signal transduction, and are associated with a more immature
and proliferative phenotype (Supplementary Figure S5A–C). In
addition, close examination showed that the downregulated
genes in the Sox2 overexpressing animals are involved in intestinal
transport and lipid handling, typical processes for the absorptive
function of the intestine (Supplementary Figure S5D).
We next used the pattern of GO term enrichment to integrate
our Sox2 profiles with a database of gastric and intestinal cells
and tissues of varying degrees of differentiation (Figure 3B).
That analysis showed that genes whose expression was induced
by ectopic Sox2 most resembled the gene expression profile of
gastric zymogenic chief cells, whereas genes whose expression
was decreased by Sox2 most resembled genes expressed in
mature intestinal cells. Thus, by GO term enrichment, Sox2
induced genes expressed by gastric cells and reduced expression
of normal intestinal genes. Ectopic Sox2 had mixed effects on
parietal cell genes, potentially because of overlap in the types
of genes that parietal cells express and those that intestinal
enterocytes express. For example, genes regulating lipid metabol-
ism are characteristic of both enterocytes and parietal cells (Mills
et al., 2001).
We followed up the global patterns of gene expression by con-
firming expression changes in individual markers with defined
rostral–caudal patterns of expression in the gastro-intestinal
tract. We analyzed markers identifying the presence of the
esophagus and non-glandular gastric basal cells, the acid-
producing glandular gastric parietal cells, and gastric mucous
neck cells. This showed that unlike the controls, the double trans-
genic animals had focal expression of p63-positive basal cells
(Figure 4A and Supplementary Figure S3D), characteristic of
basal cells of the forestomach and the esophagus. Sox2-
expressing intestines also showed abundant H+/K+ ATPase4b
positive cells of the gastric parietal lineage (Figure 4B and
Supplementary Figure S3E) and GSII lectin positive mucous neck
cells (Figure 4C) within the intestinal epithelium. Mist1, a marker
for the zymogenic chief cell lineage in adult stomach (Ramsey
et al., 2007), did not reveal a specific staining pattern (data not
shown), which is in accordance with the lack of mature chief
cells in the embryonic stomach. In addition, ectopic expression
of the stomach specific p63, H+/K+ ATPase4a, Mucin5ac
(Muc5ac, marks gastric surface pit cells), and Keratin13 (Ker13,
marks suprabasal cells) genes was detected using qPCR in the
double transgenic intestine (Figure 4D). Ectopic expression of
Sox2 in the intestinal epithelium did not clearly influence the
underlying mesenchyme, as indicated by the unchanged low ex-
pression of the stromally expressed stomach-specific gene Barx1
Figure 2 Sox2 affects the normal differentiation of intestinal epithelium. Cross-sections of the duodenum at E18.5 of controls and double trans-
genic embryos, which received doxycycline. IHC using antibodies against Mucin2 (A) and synaptophysin (B) showed a reduced number of goblet
cells and enteroendocrine cells, respectively, in the double transgenic animals (positive cells are indicated by arrows). Scale bar, 20 mm (A and
B). (C) Analysis of the expression level of marker genes of goblet cells (Muc2), enteroendocrine cells (ChgA), and enterocytes (Lct) by qPCR
showed a significant reduction of expression in the small intestine of double transgenic embryos at E18.5. Additionally, qPCR was used to de-
termine the expression levels of two genes specific to the intestinal brush border, i.e. members of the solute carrier family (Slc), Slc2a2 and
Slc5a1, which are involved in glucose transport. Both are down-regulated in double transgenic embryos. (D) PAS staining revealed the absence
of the intestinal brush border in Sox2-induced animals compared with the controls (arrows indicate the positive lining of the brush border).
Scale bar, 25 mm.
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(Figure 4D) (Stringer et al., 2012). Checking the expression of
Gastrin revealed a reduced expression (Figure 4D), which is in
line with Gastrin-producing cells being present embryonically in
the intestine and pancreas, while emerging in the stomach only
at birth (Larsson, 2000). Next, electron microscopy confirmed the
lack of microvilli on the double transgenic intestinal epithelial
cells (Figure 4E and Supplementary Figure S6). Moreover, it
showed that ectopic Sox2 expression induced a more apical
localization of the nuclei, in contrast to the basal orientation in
controls (Figure 4E).
Figure 4 Sox2 induces stomach-like cells in the intestinal environment. Cross-sections of the stomach and duodenum at E18.5 of controls and
double transgenic embryos, which received doxycycline. IHC using markers for basal cells (p63) (A) and parietal cells (H+/K+ ATPase4b) (B)
showed positive staining in the stomach. Ectopically expressed Sox2 induced the appearance of basal cells and parietal cells in duodenum of
double transgenic animals (arrows), whereas control duodenum is devoid of staining. Immunofluorescence for GSII lectin (C), a marker for the
mucous neck cells in the stomach, showed positive cells in the double transgenic intestine (arrows), while no expression was found in the
control. Scale bar, 20 mm (A–C). (D) Analysis of the expression of marker genes for basal cells (p63), suprabasal cells (Ker13), parietal
cells (H+/K+ ATPase4a), and gastric pit/surface-cell mucin (Muc5ac) by qPCR showed an increase in the small intestine of double transgenic
animals. No significant change in the expression level of the stomach-specific mesenchymal marker Barx1 was detected. Expression of the
Gastrin hormone was reduced in double transgenic animals. (E) Nuclei of normal intestinal epithelium are oriented toward the basal membrane,
whereas the nuclei of the double transgenic intestinal epithelial cells are positioned more apically, shown by EM. Bar diagram represents the
quantification of the distance of the nuclei to the apical border in control and double transgenic intestines. Scale bar, 6 mm.
Figure 3 Transcriptome analysis reveals upregulation of gastric cell-specific transcripts by Sox2. (A) OmniViz Treescape showing the hierarch-
ical clustering of Affymetrix probe sets that matched the selection query. Gene expression levels compared with the geometric mean are indi-
cated in red for upregulated genes and in blue for downregulated genes. The color intensity correlates with the degree of change. Con, control;
DT, double transgenic. (B) Sox2-upregulated and Sox2-downregulated gene lists were compared based on their associated GO term fractional
representations with previously described GO term profiles of several other gastrointestinal cells and tissues (Doherty et al., 2008). ‘Mature
intestinal crypt cells’ refers to an expression profile of genes derived from b-catenin deleted mice (Fevr et al., 2007), which causes crypt
cells to mature. ‘Hyperplastic intestinal cells’ refers to PTEN-deficient intestinal cells, which become hyperplastic (He et al., 2007).
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Collectively, our data show that Sox2 expression in the embry-
onic intestinal epithelium causes anteriorization of the intestine
with intestinal epithelial cells adopting the morphology and
gene expression profile of immature gastric cells.
Ectopic Sox2 expression in the intestine alters the functionality of
Cdx2, but not its expression level
Considering all the changes caused by Sox2 expression, we
examined whether Cdx2 expression was also decreased,
thereby fitting the suggestion that Sox2 and Cdx2 are expressed
in a mutually exclusive manner. qPCR showed that expression of
the Cdx2 mRNA was not altered (data not shown). Surprisingly,
IHC for Sox2 (Figure 5A) and Cdx2 (Figure 5B) revealed that
both transcription factors were expressed throughout the entire
intestinal epithelium of the Sox2 induced animals, whereas only
Cdx2 was expressed in the control. Moreover, nuclear
co-localization of Cdx2 and Sox2 was shown by immunofluores-
cence using confocal microscopy (Figure 5C).
Thus, although Sox2 induced cellular changes leading to the
occurrence of anterior gastro-intestinal cell types normally
devoid of Cdx2, Cdx2 remained co-expressed in the Sox2
double transgenic intestines. However, the microarray analysis
revealed several known Cdx2 target genes to be clearly downre-
gulated in these Cdx2/Sox2 positive cells, including the well-
established target gene Cdh17 (Hinoi et al., 2002). These
reduced expression levels were confirmed by qPCR for the
target genes, Hnf4a, Heph, Cdx1, and Mep1a (Figure 6A; Gao
et al., 2009; Verzi et al., 2010). Using IHC we confirmed that
the number of Hnf4a positive cells was strongly decreased in
the double transgenic animals (Figure 6B).
These results suggest that ectopic expression of Sox2 does not
directly affect the expression of Cdx2 itself, but interferes with the
subsequent activation of Cdx2 target genes. Therefore, we ana-
lyzed the binding of Cdx2 to the promoter regions of two known
target genes by chromatin immunoprecipitation (ChIP) using em-
bryonic intestines from control and double transgenic animals
(Figure 6C and Supplementary Figure S7). We show that ectopic
expression of Sox2 in the intestine leads to a strong decrease
in the binding of Cdx2 to its targets Cdh17 and Hnf4a, whereas
Sox2 does not bind to these sites. Specificity of the Sox2
ChIP was confirmed by the detection of increased binding of
Figure 5 Sox2 and Cdx2 are co-expressed. IHC on sequential sections of E18.5 duodenum showed Sox2 expression only in double transgenic
intestines (A), and Cdx2 expression throughout the epithelium in both control and double transgenic embryos (B). Confocal microscopy (C) of
control and double transgenic animals showed that Cdx2 and Sox2 are co-expressed in the same intestinal epithelial cells in Sox2 expression
embryos. Individual images of DAPI (blue), Cdx2 (green), and Sox2 (red) stainings are shown as inserts. Scale bar, 50 mm.
Figure 6 Sox2 affects the expression of Cdx2 target genes by inhibiting Cdx2 binding to target genes. (A) The expression levels of the Cdx2
target genes Hnf4a, Heph, Cdx1, and Mep1a are significantly downregulated in the small intestine of double transgenic animals at E18.5.
(B) IHC with an antibody against Hnf4a on cross-sections of duodenum at E18.5 of control and Sox2 overexpressing animals showed a dramatic
loss of staining in the double transgenic animals. Scale bar, 20 mm. (C) ChIP assay showed a dramatic loss of binding of Cdx2 to Cdh17 and
Hnf4a in the double transgenic animals. Amylase served as a negative control.
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Sox2 to its target Sox21 in the double transgenic embryos
(Supplementary Figure S7). Thus, ectopic Sox2 expression in
the intestinal tract does not affect the expression of Cdx2, but
inhibits its function as a transcriptional regulator by interfering
with the binding of Cdx2 to its gene target sites, which in turn pre-
vents the activation of the intestinal transcriptome.
Discussion
During development of the gastro-intestinal tract, Sox2 is
expressed in the anterior part of the primitive gut, while the
homeobox gene Cdx2 is expressed in the posterior part
(Sherwood et al., 2009). Various studies have suggested that
the expression of Sox2 and that of Cdx2 are mutually exclusive,
but it remains elusive whether one of the two is dominant over
the other. Therefore, we ectopically expressed Sox2 in the pro-
spective intestinal part of the primitive gut to investigate
whether Sox2 has a dominant role over Cdx2 in the specification
of the developing endoderm. We show that ectopic expression of
Sox2 in the posterior region of the primitive gut caused aberrant
activation of the foregut transcriptional program, leading to ante-
riorization of the gut with features resembling those of an imma-
ture embryonic stomach. Sox2 induction did not alter Cdx2
expression, but interfered with its function as a transcriptional
regulator, providing evidence that Sox2 can exert a dominant
effect over Cdx2 on cell fate.
Ectopic expression of Sox2 in the embryonic intestinal tract
leads to a translucent and dilated intestine, which had a reduced
number of villus-like outfoldings per surface area. These villi
were poorly developed and showed increased numbers of
cycling cells that were no longer confined to the intervillous
regions, but were localized randomly throughout the intestinal epi-
thelium. The differentiation toward goblet cells, enteroendocrine
cells, and enterocytes was dramatically affected. Instead, the
Sox2-expressing epithelium differentiated into gastric-like cell
types, such as parietal cells and basal cells, demonstrated by
IHC, qPCR, and GO term analysis. GO term comparative expression
profile analysis also revealed that the genes upregulated by Sox2
were closer to cells of mature gastric zymogenic chief cell differen-
tiation than to any of a variety of normal intestinal tissue gene ex-
pression profiles. These dramatic changes were accomplished in
the short time-frame that ectopic Sox2 becomes expressed, i.e.
E14.5–E18.5, demonstrating the dominant influence of Sox2 in
the developing gut. Apparently, Sox2 is able to convert the cell
fate of already committed embryonic intestinal cells into stomach-
like cells. The prominent effect of Sox2 in determining cell fate was
also highlighted by our previous study, in which we have shown
that ectopic expression of Sox2 in the lung also results in dramatic
changes in differentiation (Gontan et al., 2008).
The fluid filled, swollen appearance of intestines of the
Sox2-induced animals is most likely caused by the dramatic
decreased number of enterocytes combined with the disruption
of the intestinal brush border. As a consequence of the decreased
absorptive area, fluid cannot be absorbed by the intestine, re-
sulting in fluid retention. Our studies with ectopic Sox2 expres-
sion in intestines of mouse embryos complement a recent study
reporting the effect of Cdx2 ablation in mouse embryos (Gao
et al., 2009). Cdx2 ablation severely affects the normal intestinal
development, since mutant embryos fail to form the colon and
rectum properly. Furthermore, the duodenum of the Cdx2
mutant animals was distended and became translucent. Also
the disturbed proliferative pattern strongly resembles our obser-
vations. In our study the total number of epithelial cells was not
significantly altered (data not shown), which is in accordance with
the equal number of cells in the mitotic phase of the cell cycle as
revealed by phospho-Histone H3 staining (20%–25% for both
genotypes, data not shown). These results indicate that although
Sox2 expression strongly affects the number and position of
cycling cells, it most likely also leads to an increased duration
of the cell cycle, effectively resulting in an equal production of
epithelial cells.
Interestingly, Gao et al. (2009) also showed ectopic activation
of Sox2 in the Cdx2 mutant intestine, which implied that Sox2
may have been responsible for inducing the phenotypes that
were observed. Our results strongly support this concept, as we
demonstrated that Sox2 induces the differentiation toward a pre-
mature stomach phenotype, in spite of sustained Cdx2 expres-
sion. We conclude that loss of Cdx2 by itself is not sufficient to
drive the activation of the foregut transcriptional program, but
requires expression of Sox2 to dominantly induce anteriorization.
Inactivation of Cdx2 in adult intestines induced the expression
of gastric markers, but did not lead to major morphological
changes (Stringer et al., 2012). Although these authors showed
that the gut stem cells in the crypts showed some plasticity to
express gastric genes, the plasticity of the cells in the developing
gut is much greater since Gao et al. (2009) and we showed com-
plete induction of gastric genes and cell types. This indicates that
the adult intestinal epithelial cells have partly lost their potential
to change their fate upon Cdx2 ablation. In support of this, we
also observed reduced plasticity when Sox2 is ectopically
induced in adult animals (unpublished data).
More recently, Cdx2 was shown to also regulate epithelial cell
polarity (Gao and Kaestner, 2010). Depletion of Cdx2 in the devel-
oping mouse embryo from E15.5 onward, i.e. equivalent to the
time point that we induce Sox2, led to the formation of irregular
packed epithelial cells containing large subapical vacuoles and a
disorganized pattern of several apical and basolateral markers. In
our case, staining for ZO-1 (apical), E-cadherin (basolateral), and
laminin-1 (basement membrane) revealed that epithelial polarity
was not clearly affected (data not shown). We also did not
observe the vacuoles and irregular packing of epithelial cells.
These differences in phenotype are possibly explained by the in-
complete functional downregulation of Cdx2 induced by Sox2
expression.
Ectopic expression of Sox2 did not affect the expression of the
intestinal specific transcription factor Cdx2. This is in apparent
contrast with work published by Benahmed et al. (2008), who
investigated the regulation of Cdx2 expression. Using cellular
approaches with a 13 kb genomic fragment covering part of the
Cdx2 locus, they showed that Sox2 had a profound inhibitory
effect on Cdx2 transcriptional activity. As our study shows that
the endogenous locus is not affected by Sox2, this either
implies that the proposed Sox2-binding site in the 13 kb fragment
is not easily accessible in the endogenous setting or that for
proper Cdx2 regulation additional domains are required, e.g.
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the 3′ located enhancer. Previous studies have provided limited
data to suggest that Cdx2 regulates Sox2 expression, but no
direct binding of Cdx2 to the Sox2 promoter region was shown
(Gao et al., 2009; Sherwood et al., 2009; Mutoh et al., 2011).
Nishiyama et al. (2009) recently described a genome-wide ana-
lysis of Cdx2 target sites using ChIP technology and clearly
demonstrated that Cdx2 did not bind to the Sox2 locus. Verzi
et al. (2010) analyzed the Caco-2 intestinal carcinoma cell line
for putative CDX2-binding sites and identified a ChIP peak in an
intergenic region in proximity to the SOX2 locus. However, it
remains unclear whether the binding site had functional rele-
vance to the SOX2 gene.
Although Cdx2 was not affected at the transcriptional level, its
function is severely affected as deduced from the strong downre-
gulation of several Cdx2 target genes. We show that Sox2 inter-
feres with the binding of Cdx2 to its genomic target sites,
thereby preventing its transcriptional activity. At present, the
precise molecular mechanism to explain the inhibitory effect on
Cdx2 DNA binding is unclear. Possibly Sox2 competes with
co-factors that are needed by Cdx2 for its binding activity (Verzi
et al., 2010), or Sox2 may induce differentiation into cell types
that lack the expression of factors required by Cdx2 to bind effi-
ciently to its target sequences.
In conclusion, we show that ectopic expression of Sox2 leads to
impairment of villus formation and strongly alters the appearance
of the normal intestinal epithelium. We show anteriorization of the
primitive gut, demonstrated by cell fate conversion from intestinal
epithelial into immature stomach-like cells. This demonstrates the
dominant influence of Sox2 in the developing gut, since Sox2 is
able to convert the cell fate of already committed intestinal cells
into stomach-like cells. Sox2 induction does not alter Cdx2 expres-
sion, but inhibits its function as transcriptional activator by inter-
fering with its DNA-binding capacity. This supports the idea that
a balance between Sox2 and Cdx2 may dictate proper patterning
of the foregut endoderm and that Sox2 may exert a dominant
effect on intestinal cell fate by altering the differentiation
program, emphasizing the plasticity of the primitive gut.
Our work improves the understanding of the mechanisms
underlying the formation of the gastrointestinal tract and pro-
vides insight into the possible origin of various human congenital
anomalies of the gut, such as Meckel’s diverticulum, in which
ectopic gastric tissue can be present in the small intestine. In add-
ition, it may clarify the functional consequences of the ectopic
SOX2 expression that we and others observed in human colorec-
tal cancer (unpublished data; Park et al., 2008).
Materials and methods
Transgenic animals
The myc-Sox2 and Villin-rtTA transgenic mouse lines were pre-
viously described (Gontan et al., 2008; Roth et al., 2009).
Administration of doxycycline to dams from E8.5 or E14.5
onward in the drinking water (2 mg/ml doxycycline, 5%
sucrose) induced expression of myc-Sox2 in intestinal epithelium
of double transgenic embryos. Each experiment was performed
on at least three independent litters containing double transgen-
ic, single transgenic and wild-type pups. All double transgenic
animals receiving doxycycline expressed nuclear Sox2 in the
intestinal epithelium throughout the entire intestinal tract and
showed described phenotype.
Histology
Embryos were obtained by caesarean section at E18.5. The
gastro-intestinal tract was isolated and stretched on pieces of
filter paper, followed by fixation in 4% phosphate-buffered
saline (PBS)-buffered paraformaldehyde (PFA) overnight at 48C.
Intestines were cut into four to five pieces and pre-embedded
in 5% bacto-agar (BD) in PBS, before being embedded in paraffin
according to routine protocols.
IHC, PAS staining and electron microscopy were performed as
described previously (Darbas et al., 2004; Huang et al., 2012).
Antibodies are listed in Supplementary Table S1. Differentiated
and proliferative cells in the epithelium were quantified by count-
ing at least three microscopic fields relative to the total number of
epithelial cells.
Microarray analysis
The intestinal tracts of three control and two double transgenic
embryos, which received doxycycline from E8.5 onward, were iso-
lated at E18.5 and individually used for transcriptome analysis
using Affymetrix Mouse Genome 430 2.0 microarrays as previous-
ly described (Gontan et al., 2008). Subsequent analysis of the
data were performed as described in detail in Supplementary
Materials and methods.
Chromatin immunoprecipitation
Small intestines of 10 double transgenic and 10 control E18.5
embryos were pooled and mechanically disrupted. Subsequently,
the material was crosslinked, sonicated, and used to immunopreci-
pitate either Cdx2 or Sox2 complexes. The precipitated material
was de-crosslinked and the co-immunoprecipitated DNA fragments
were used as template in qPCR reactions to amplify specific target
sequences (primers are listed in Supplementary Table S2). Details
of the protocol are provided in Supplementary Materials and
methods.
Quantitative polymerase chain reaction
RNA isolation, cDNA synthesis, and subsequent qPCR analysis
were performed as previously described (Rajatapiti et al., 2008).
Data were analyzed using the 22DDCt-method (Livak and
Schmittgen, 2001). The gene-specific primers used are listed in
Supplementary Table S3.
Supplementary material
Supplementary material is available at Journal of Molecular Cell
Biology online.
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